Trademark Overview
On Wednesday, February 18, 2026, a trademark application was filed for LYTSTARIQ with the United States Patent and Trademark Office. The USPTO has given the LYTSTARIQ trademark a serial number of 99659510. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 18, 2026. This trademark is owned by Ocugen, Inc.. The LYTSTARIQ trademark is filed in the Pharmaceutical Products category with the following description:
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy for the treatment of ocular disease, such as Stargardt Disease; Pharmaceutical preparations for gene therapy for the treatment of Stargardt Disease